Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nelson HS et al. - Results were available on 12 adult subjects who received mometasone and 14 subjects who received placebo. Among tests reflecting small airway patency, the forced expiratory flow between 25 and 75% of vital capacity was significantly improved by mometasone compared with placebo. Other results significantly favoring mometasone over placebo included FEV1, FVC, PC20, and A.M. and P.M. peak expiratory flows, and albuterol use.


Today in Cardiovascular/Pulm...keeping you current

Role of adenoids and adenoiditis in children with allergy and otitis media
Current Allergy and Asthma Reports, 10/22/09

Pediatric Asthma: An Integrative Approach to Care
Nutrition in Clinical Practice, 10/22/09

From asthma severity to control: a shift in clinical practice
Primary Care Respiratory Journal, 10/19/09

Today in Clinical Pharmacology...keeping you current

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

Zinc: role in immunity, oxidative stress and chronic inflammation
Current Opinion in Clinical Nutrition & Metabolic Care, 10/21/09

Anti-Inflammatory Drugs in Psychiatry
Inflammation & Allergy - Drug Targets, 10/09/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address